Atlantic Lipid Lowering Treatment Optimization Program — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Atlantic Lipid Lowering Treatment Optimization Program — Stella

Home/Familial Hypercholesterolemia/

View on ClinicalTrials.gov

Recruiting

Back to Familial Hypercholesterolemia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Atlantic Medical Group, Clark, New Jersey

Atlantic Medical Group, Springfield, New Jersey

Key details

Sponsor

Atlantic Health System

Collaborators

Regeneron Pharmaceuticals

Enrollment target

~250 participants

Started

July 2024

Primary completion

May 2027

Age range

18 Years – 120 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.